
Source: iQoncept / Shutterstock
NextCure (NASDAQ:NXTC) recently showcased its mettle by unveiling its performance for the fourth quarter of 2023.
- Delving into figures, NextCure reported earnings per share of -52 cents, a notable victory surpassing the analyst projection of -54 cents for EPS.
- In a surprising twist, the financial report did not unveil any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/nxtc-stock-earnings-nextcure-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC